To Explore the Safety and Efficacy of Intravenous Infusion of Different Doses of Lidocaine in Patients

NCT05369650 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Liver Cancer

Interventions

DRUG: Lidocaine Hydrochloride, Injectable

Sponsor

West China Hospital